Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms
Vaccines · 01.05.2026 · 14 (5) · 409
DOI: 10.3390/vaccines14050409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 01.05.2026. Verfasst von Nurika Assanzhanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Institute for Biological Safety Problems., Ministry of Health of the Republic of Kazakhstan.
Abstract (Originalsprache)
Brucellosis remains one of the most widespread zoonotic infections worldwide, causing serious veterinary, medical, and socio-economic consequences. The disease, caused by bacteria of the genus Brucella, affects a wide range of domestic and wild animals as well as humans, with global incidence potentially reaching 1.6–2.1 million new cases annually. The most effective approach to combating brucellosis is specific prevention through vaccination. Therefore, we conducted this review to summarize data from existing studies on modern strategies for brucellosis vaccination, types of vaccine platforms, their efficacy, safety, and applicability in veterinary and human medicine. We searched databases including PubMed, Scopus, and Web of Science to identify relevant scientific articles in English published from 1990 to 2025. The aim of this work is to conduct a systematic analysis of modern brucellosis vaccination strategies in livestock and humans, as well as to evaluate the prospects of new vaccine platforms. The review examines live attenuated, inactivated, subunit, vector, and DNA vaccines, as well as their immunological mechanisms of action, advantages, and limitations of application. This information allows for a better understanding of the mechanisms of protective immunity formation and challenges related to DIVA diagnostics (Differentiating Infected from Vaccinated Animals). The “One Health” concept demonstrated the interconnection between human, animal, and environmental factors, emphasizing the need for an interdisciplinary approach to brucellosis monitoring, prevention, and control. Vector vaccines based on influenza virus (Flu-BA), developed in Kazakhstan, have shown high promise, combining immunogenicity, protective efficacy, and a favorable safety profile. Promising directions remain mRNA vaccines, nanoparticles, CRISPR/Cas9 technologies, and mucosal vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute for Biological Safety Problems, National Holding "QazBioPharm", Gvardeiskiy 080409, Kazakhstan.
ORCID-Profile: Nurika Assanzhanova, Kuandyk Zhugunissov, Olga Chervyakova, Nurlan Akmyrzayev, Aigerim Sagymbayeva, Yeldos Myrzakhmetov, Aigerim Mailybayeva
Förderung
- Research Institute for Biological Safety Problems.
- Ministry of Health of the Republic of Kazakhstan
Zitieren
APA
Assanzhanova, N., Zhugunissov, K., Chervyakova, O., Ryskeldinova, S., Akmyrzayev, N., Sagymbayeva, A., Myrzakhmetov, Y., & Mailybayeva, A. (2026). Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms. Vaccines, 14(5), 409. https://doi.org/10.3390/vaccines14050409
Vancouver
Assanzhanova N, Zhugunissov K, Chervyakova O, Ryskeldinova S, Akmyrzayev N, Sagymbayeva A, et al. Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms. Vaccines. 2026;14(5):409. doi:10.3390/vaccines14050409
BibTeX
@article{Assanzhanova2026,
author = {Assanzhanova, Nurika and Zhugunissov, Kuandyk and Chervyakova, Olga and Ryskeldinova, Sholpan and Akmyrzayev, Nurlan and Sagymbayeva, Aigerim and Myrzakhmetov, Yeldos and Mailybayeva, Aigerim},
title = {Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative Platforms},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {409},
doi = {10.3390/vaccines14050409}
}
EUVIMED